Compare AU & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AU | HLN |
|---|---|---|
| Founded | 1944 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Precious Metals | Package Goods/Cosmetics |
| Sector | Basic Materials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.5B | 42.8B |
| IPO Year | 2023 | 2021 |
| Metric | AU | HLN |
|---|---|---|
| Price | $93.93 | $8.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $119.00 | N/A |
| AVG Volume (30 Days) | 1.7M | ★ 18.5M |
| Earning Date | 05-08-2026 | 02-26-2026 |
| Dividend Yield | ★ 3.94% | 1.94% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $38.71 | $6.55 |
| Revenue Next Year | $2.89 | $4.42 |
| P/E Ratio | ★ $23.93 | $49.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $62.55 | $8.65 |
| 52 Week High | $129.14 | $11.28 |
| Indicator | AU | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 37.65 | 33.48 |
| Support Level | $89.75 | $8.89 |
| Resistance Level | $98.06 | $10.20 |
| Average True Range (ATR) | 2.66 | 0.14 |
| MACD | -1.65 | -0.02 |
| Stochastic Oscillator | 13.20 | 5.21 |
Anglogold Ashanti PLC is an independent gold mining company. It has a diversified asset portfolio, including production from operations in eight countries (Argentina, Australia, Brazil, Egypt, Ghana, Guinea, the DRC, and Tanzania), supported by greenfield projects in the United States and Colombia. The company's main product is gold, which once mined, is processed into dore (unrefined gold bars) on site and then dispatched to precious metals refineries. Geographically, Anglogold generates maximum revenue from its operations in Africa (comprising operations at Kibali, Iduapriem, Obuasi, Siguiri, Geita, and Sukari mines), followed by Australia (including Sunrise Dam and Tropicana), and the Americas (comprising Cerro Vanguardia, AngloGold Ashanti Mineracao, and Serra Grande operations).
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.